Emeis

EMEIS

Equity

ISIN FR001400NLM4 / Valor 132546338

Euronext - Euronext Paris (2025-10-17)

EUR 14.49-1.02%

Emeis
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Orpea SA is a France-based company that operates nursing homes, post-acute care clinics, psychiatric hospitals, and homecare services.

Summarized from source with an LLMView SourceSector: Healthcare

Sales Performance

For H1 2025, Emeis projects sales of €2,772 million, reflecting a +55% increase compared to H1 2023. This growth underscores the company's strong market presence and effective sales strategies.

EBITDA Growth

EBITDA for the first half of 2025 is estimated at €2,539 million, marking a +15% rise from H1 2023. This improvement highlights Emeis's enhanced operational efficiency and profitability.

Disposals and Strategic Moves

Since mid-2022, Emeis has accumulated disposals amounting to €1.15 billion. Notably, €13 million pertains to the disposal of Emeis’s activities in the Czech Republic, indicating strategic realignments within the company's portfolio.

Occupancy Rates

Occupancy rates remain robust in France and Germany, with France maintaining an average of 85.5% in Q1 2025 and Germany at 83.4%. These steady figures demonstrate Emeis's strong foothold in these key markets.

EBITDA Margin

The EBITDA margin, excluding IFRS-16, stands at 3.3% for H1 2025, a slight decrease from 8.9% in H1 2024. This adjustment reflects changes in operational costs and market conditions.

Summarized from source with an LLMView Source

Key figures

172%1Y

%3Y

%5Y

Performance

73.0%1Y

250%3Y

250%5Y

Volatility